The Gross Margin of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS) is 61.58%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 61.58% |
| 2024-03-31 | 55.14% |
| 2023-03-31 | 56.77% |
| 2022-03-31 | 59.89% |
| 2021-03-31 | 57.02% |
| 2020-03-31 | 64.56% |
| 2019-03-31 | 56.33% |
| 2018-03-31 | 51.67% |
| 2017-03-31 | 58.54% |
| 2016-03-31 | 58.97% |